Menarini Stemline

The Menarini Stemline team in France is honored to participate in the 10th Monaco Age Oncologie conference this week! This exceptional event focuses on the unique challenges of treating cancers in aging populations, fostering collaboration and innovation to improve patient outcomes. At Menarini Stemline, we are committed to improving the outcomes for those impacted by breast cancer, the most commonly diagnosed cancer in women worldwide. #Oncology #Aging #InnovationInHealthcare #MenariniStemlineFrance

This week the Menarini Stemline team in Spain came together for the first cycle meeting of the year. We are looking forward to 2025, as we kick off a new chapter of opportunity to help our patient communities! 

Today, on BPDCN Day, we stand in solidarity with those living with BPDCN, their caregivers and the advocacy community. At Menarini Stemline, we remain dedicated to advancing innovation and research to help improve outcomes for those impacted by this rare and aggressive cancer. Learn more at BPDCNinfo.com #BPDCN #RareCancerAwareness

The Menarini Stemline team in France is proud to participate in the first Cours St-Paul in Hematology this week! This inaugural event marks a milestone in advancing knowledge and collaboration in hematology. Menarini Stemline is committed to addressing unmet needs and delivering innovative solutions for patients with rare and complex hematological conditions. If you are onsite, be sure to visit our booth! #Hematology #InnovationInHealthcare #Collaboration #MenariniStemlineFrance

Today we pause to reflect on the values of equality, justice and service that Dr. Martin Luther King, Jr. championed during his career. We are proud to honor Dr. King’s legacy by continuing to work toward a brighter and healthier future for all. #MLKDay

In France, breast cancer affects 61,000 women and is responsible for 12,000 deaths annually. At the #CoursSaintPaul, Menarini Stemline France is proud to collaborate and connect with the breast cancer community. If you’re onsite, be sure to visit our booth to learn more about Menarini Stemline’s commitment to advancing oncology care and building hope. #Oncology #BreastCancer #InnovationInHealthcare #MenariniStemlineFrance

Menarini Group and Insilico Medicine announce a second global exclusive license agreement for a highly selective small molecule targeting solid tumor cancers, developed through Insilico’s generative AI platform. This follows their first agreement in January 2024 for MEN2312, an innovative molecule for the potential treatment of breast cancer. Read today’s press release here: https://lnkd.in/dgi6xyby #Menarini #Stemline #Oncology #Innovation #AI

Happy New Year from Menarini Stemline! As we step into 2025, our team is eager to continue driving innovation in cancer treatment and serving our patient communities. 

Wishing our followers a joyful holiday season! As we reflect on the year, we are grateful for our dedicated team and their commitment to the work we do for individuals living with cancer. Here’s to a prosperous New Year ahead! 

Our team had an incredible experience connecting with the oncology community at #SABCS24 and sharing our latest updates for individuals living with breast cancer. We are looking forward to continuing our work to help improve outcomes for the patient community!